Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease - PubMed (original) (raw)
Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease
Jonathan Himmelfarb et al. Kidney Int. 2003 Sep.
Free article
Abstract
Background: The metabolism of alpha and gamma tocopherol, the major components of vitamin E, have not been studied in uremic patients. The major pathway of tocopherol metabolism is via phytyl side chain oxidation, leaving carboxyethyl-hydroxychromans (CEHC) as metabolites. Alpha and gamma CEHC are water soluble, renally excreted, with known potent anti-inflammatory and antioxidative properties.
Methods: We examined serum alpha and gamma tocopherol and respective CEHC concentrations in 15 healthy subjects and 15 chronic hemodialysis patients.
Results: Serum alpha tocopherol levels were similar in hemodialysis patients (12.03 +/- 1.34 microg/mL) and healthy subjects (11.21 +/- 0.20 microg/mL), while serum gamma tocopherol levels were significantly greater in hemodialysis patients (3.17 +/- 0.37 microg/mL) compared to healthy subjects (1.08 +/- 0.06 microg/mL, P < 0.0001). Serum alpha and gamma CEHC levels were tenfold and sixfold higher in hemodialysis patients compared to healthy subjects, respectively (both P < 0.0001). Serum alpha and gamma tocopherol levels and CEHC metabolites were also measured after supplementation of alpha- or gamma-enriched mixed tocopherols in both hemodialysis patients and healthy subjects. Tocopherol administration resulted in modest or nonsignificant changes in serum tocopherol concentrations, while markedly increasing serum CEHC concentrations in both healthy subjects and hemodialysis patients. Hemodialysis resulted in no change in the serum alpha or gamma tocopherol concentrations while decreasing serum alpha CEHC and gamma CEHC levels by 63% and 53%, respectively (both P = 0.001 versus predialysis). Fourteen-day administration of gamma-enriched but not alpha tocopherols lowered median C-reactive protein (CRP) significantly in hemodialysis patients (4.4 to 2.1 mg/L, P < 0.02).
Conclusion: First, serum alpha and gamma CEHC accumulate in uremic patients compared to healthy subjects; second, supplementation with tocopherols dramatically increases serum CEHC levels in both healthy subjects and hemodialysis patients; and, finally, CEHC accumulation may mediate anti-inflammatory and antioxidative effects of tocopherols in hemodialysis patients.
Similar articles
- Accumulation of vitamin E metabolites in the blood of renal failure patients.
Galli F, Floridi AG, Floridi A, Buoncristiani U. Galli F, et al. Clin Nutr. 2004 Apr;23(2):205-12. doi: 10.1016/S0261-5614(03)00128-6. Clin Nutr. 2004. PMID: 15030960 - Tocopherol metabolites 2, 5, 7, 8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman (alpha-CEHC) and 2, 7, 8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (gamma-CEHC) in human serum after a single dose of natural vitamin E.
Radosavac D, Graf P, Polidori MC, Sies H, Stahl W. Radosavac D, et al. Eur J Nutr. 2002 Jun;41(3):119-24. doi: 10.1007/s00394-002-0365-3. Eur J Nutr. 2002. PMID: 12111049 - Studies in humans using deuterium-labeled alpha- and gamma-tocopherols demonstrate faster plasma gamma-tocopherol disappearance and greater gamma-metabolite production.
Leonard SW, Paterson E, Atkinson JK, Ramakrishnan R, Cross CE, Traber MG. Leonard SW, et al. Free Radic Biol Med. 2005 Apr 1;38(7):857-66. doi: 10.1016/j.freeradbiomed.2004.12.001. Free Radic Biol Med. 2005. PMID: 15749381 - gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention.
Jiang Q, Christen S, Shigenaga MK, Ames BN. Jiang Q, et al. Am J Clin Nutr. 2001 Dec;74(6):714-22. doi: 10.1093/ajcn/74.6.714. Am J Clin Nutr. 2001. PMID: 11722951 Review. - New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine.
Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L, Mou S, Pye QN, Stoddard MF, Wallis G, Williamson KS, West M, Wechter WJ, Floyd RA. Hensley K, et al. Free Radic Biol Med. 2004 Jan 1;36(1):1-15. doi: 10.1016/j.freeradbiomed.2003.10.009. Free Radic Biol Med. 2004. PMID: 14732286 Review.
Cited by
- Anti-atherosclerotic effects of vitamin E--myth or reality?
Munteanu A, Zingg JM, Azzi A. Munteanu A, et al. J Cell Mol Med. 2004 Jan-Mar;8(1):59-76. doi: 10.1111/j.1582-4934.2004.tb00260.x. J Cell Mol Med. 2004. PMID: 15090261 Free PMC article. Review. - Physiological Mechanisms of Hypertension and Cardiovascular Disease in End-Stage Kidney Disease.
Clemmer JS, Shafi T, Obi Y. Clemmer JS, et al. Curr Hypertens Rep. 2022 Oct;24(10):413-424. doi: 10.1007/s11906-022-01203-7. Epub 2022 Jun 16. Curr Hypertens Rep. 2022. PMID: 35708820 Free PMC article. Review. - Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy.
Jiang Q. Jiang Q. Free Radic Biol Med. 2014 Jul;72:76-90. doi: 10.1016/j.freeradbiomed.2014.03.035. Epub 2014 Apr 3. Free Radic Biol Med. 2014. PMID: 24704972 Free PMC article. Review. - Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.
Walter PB, Fung EB, Killilea DW, Jiang Q, Hudes M, Madden J, Porter J, Evans P, Vichinsky E, Harmatz P. Walter PB, et al. Br J Haematol. 2006 Oct;135(2):254-63. doi: 10.1111/j.1365-2141.2006.06277.x. Br J Haematol. 2006. PMID: 17010049 Free PMC article. - Dietary terpenoids and prostate cancer chemoprevention.
Rabi T, Gupta S. Rabi T, et al. Front Biosci. 2008 May 1;13:3457-69. doi: 10.2741/2940. Front Biosci. 2008. PMID: 18508447 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous